Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperlipidemia and progressive renal disease.

W F Keane1, W S Mulcahy, B L Kasiske

  • 1Department of Medicine, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis.

Kidney International. Supplement
|April 1, 1991
PubMed
Summary

Abnormal lipid metabolism significantly worsens kidney damage, especially with existing conditions like diabetes. Lowering blood lipids may protect against progressive renal injury.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OPTN/SRTR 2020 Annual Data Report: Living Donor Collective

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2022
Same author

OPTN/SRTR 2020 Annual Data Report: Heart.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2022
Same author

OPTN/SRTR 2020 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2022
Same author

OPTN/SRTR 2019 Annual Data Report: Lung.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2021
Same author

OPTN/SRTR 2019 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2021
Same author

OPTN/SRTR 2019 Annual Data Report: Heart.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2021

Area of Science:

  • Nephrology
  • Metabolic Research
  • Pathophysiology

Background:

  • Abnormal lipid metabolism is increasingly recognized as a factor in progressive renal damage.
  • Diet-induced hypercholesterolemia can cause glomerular injury, which is amplified by reduced nephron populations or co-existing renal diseases like diabetes, nephrotic syndrome, and hypertension.

Purpose of the Study:

  • To explore the interaction between renal disease and lipid metabolism abnormalities.
  • To investigate the role of lipids in the progression of kidney injury.
  • To examine potential mechanisms by which lipids exacerbate glomerular damage.

Main Methods:

  • Review of experimental studies on dietary-induced hypercholesterolemia and renal injury.
  • Analysis of studies involving pharmacological interventions to reduce circulating lipids and their effect on glomerular damage.

Related Experiment Videos

  • Examination of proposed mechanisms of lipid-mediated glomerular injury.

    • Main Results:

    • Dietary hypercholesterolemia causes modest glomerular injury, but this is significantly exacerbated in the presence of underlying renal conditions.
    • Pharmacological reduction of circulating lipids correlates with decreased glomerular damage, supporting a role for lipids in renal injury progression.
    • Potential mechanisms include interactions with macrophages, altered vascular and mesangial functions, and changes in mediator substance production.

    Conclusions:

    • A significant interaction exists between renal disease and abnormal lipid metabolism, contributing to progressive renal damage.
    • Lipids may amplify glomerular injury through various cellular and molecular pathways.
    • Further clinical research is needed to understand the role of lipid abnormalities in human kidney disease progression.